title: Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder.
abstract: The integration of tobacco cessation treatment into mental health care for posttraumatic stress disorder (PTSD), known as Integrated Care (IC), was evaluated in an uncontrolled feasibility and effectiveness study. Veterans (N = 107) in PTSD treatment at two outpatient clinics received IC delivered by mental health practitioners. Outcomes were seven-day point prevalence abstinence measured at two, four, six, and nine months post-enrollment and repeated seven-day point prevalence abstinence (RPPA) obtained across three consecutive assessment intervals (four, six, and nine months). Abstinence rates at the four assessment intervals were 28%, 23%, 25%, and 18%, respectively, and RPPA was 15%. The number of IC sessions and a previous quit history greater than six months predicted RPPA. Stopping smoking was not associated with worsening PTSD or depression.
authors.affiliation: Northwest Network Mental Illness Research, Education and Clinical Center, Seattle, Washington, USA. miles.mcfall@va.gov
authors.forename: Miles
authors.initials: M
authors.lastname: McFall
authors.forename: David C
authors.initials: DC
authors.lastname: Atkins
authors.forename: Dan
authors.initials: D
authors.lastname: Yoshimoto
authors.forename: Charles E
authors.initials: CE
authors.lastname: Thompson
authors.forename: Evan
authors.initials: E
authors.lastname: Kanter
authors.forename: Carol A
authors.initials: CA
authors.lastname: Malte
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Saxon
mesh_terms: D001521:Behavior Therapy; D016642:Bupropion / Q000008:administration & dosage; D019090:Case Management; D003130:Combat Disorders / Q000453:epidemiology / Q000628:therapy*; D003131:Combined Modality Therapy; D015897:Comorbidity; D004333:Drug Administration Routes; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage; D011613:Psychotherapy; D055502:Secondary Prevention; D012907:Smoking / Q000453:epidemiology / Q000523:psychology; D016540:Smoking Cessation / Q000523:psychology*; D013313:Stress Disorders, Post-Traumatic / Q000628:therapy*; D016896:Treatment Outcome; D014728:Veterans / Q000523:psychology*
chemical_list: D016642:Bupropion; D009538:Nicotine